I have read this post a hundred times. This never happens - a conference never moves the pps, as it is not a venue for new disclosures. It will definitely "go well", yet the price will not move "sharply" unless a REAL event occurs on the same day.
More information on launch date for VIVUS moved the stock price by 8% on this Monday/Tuesday.
At some point-Amarin will announce details of launch date--will it be around Oct.4th?
Looked at AMCP 2011-- Vertex was there like VIVUS,AMARIN.
Vertex was the most successful launch compared to Merck-which had 2 weeks headstart from FDA and most experienced sales force.GOOD EDUCATION of Doctors and Pharmacists turned INCIVEK a blockbuster drug in first 2 quarters of launch,(over half billion$).
I looked at other participant in 2011--NOVO NORDISK talked about HYPOGLYCEMIA--to promote their products for Type 1 Type 2 medicines. EDUCATION is key to Sales.
Launch details should push the stock up--assuming it is a good plan.It did for VIVUS.